|
|
|
|
 |
February 2, 2012 | ISSUE NUMBER 236 VOL 8 |
Healthcare Economics
The Three Ps of Effectiveness Research:
PCORI, Priorities, and Politics
If you ever wanted to know what health economists might do with a $1 billion, the Obama Administration's Patient-Centered Outcomes Research Institute is about to tell all—not right down to the penny, but good enough ...Read More
Products
Pharm Exec's Brand of the Year
Ben Comer presents a sneak preview of Pharm Exec's Brand of the Year, a product still growing after a decade on the market, with total sales of $7.9 billion in 2011 ...Read More
Advertisement
CBI's Bio/Pharma Regulatory Policy Exchange
May 7-8, 2012 Washington, D.C.
Prepare for a new wave of legislative and regulatory policies that will shape the life sciences industry for years to come.
Learn best practices on how the shifting regulatory and policy landscape will affect the biopharma industry going forward with Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Eisai, Eli Lilly and Company, EMD Serono, Merck, Novartis and Shire Pharmaceuticals!
Register by March 10th at http://www.cbinet.com/policyexchange
and save $300 with priority code: QSS925. |
Deals
Roche Up the Stakes on Personalized Medicine
Roche's $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics, shows that Big Pharma is continuing to invest in this emerging field ...Read More
Ad Stars 2012
Last Call for Entries!
It's that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We'd like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information
Advertisement
CBI's 4th Annual Summit on Clinical Trial Investigator Portals
May 15-16, 2012 * Philadelphia, PA
Provide High-Quality Data to Study Teams for Real-Time Reporting
Learn best practices in utilizing clinical portals for efficient study start-up reducing trial costs workload of clinical investigator sites with Merck & Co., Inc., Quintiles, GlaxoSmithKline, and more!!! Register by May 15, 2012 at http://www.cbinet.com/portals and save $300 with priority code: GMA284. |
|
|

|
// Roche Diagnostics (Penzberg, Germany) announced Dan Zabrowski as the new Head of Roche Applied Science.
// Intellipharmaceutics International Inc. (Toronto) announced that its US subsidiary, Intellipharmaceutics Ltd., appointed Ira Baeringer as its Vice President, Business Development. // Stephan Henauer, MD, was appointed Executive Director of i3 Pharma
Resourcing (Princeton, N.J.)
.
|
 |
// MFlashpoint Medica (New York) hired Nicole Johnson as SVP, Director of Digital Strategy; Robin Roberts as SVP, Management Supervisor and Director of Client Service Development; and Yaron Landow as SVP, Director of Strategic Services. |
|
|
 |
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
 |
 |
 |
What is your preferred social media tool?
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|